{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:48:23Z","timestamp":1775155703915,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.leukres.2011.12.019","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T18:19:56Z","timestamp":1328725196000},"page":"407-412","source":"Crossref","is-referenced-by-count":8,"title":["Are low-intensity induction strategies better for older patients with acute myeloid leukemia?"],"prefix":"10.1016","volume":"36","author":[{"given":"Gail J.","family":"Roboz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usama","family":"Wissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen K.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usama","family":"Gergis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Scandura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Christos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.12.019_bib0005","unstructured":"National Cancer Institute. Acute Myeloid Leukemia \u2013 Surveillance Epidemiology and End Results Stat Fact Sheets: Acute Myeloid Leukemia. http:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html [accessed 15.07.2011]."},{"key":"10.1016\/j.leukres.2011.12.019_bib0010","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.12.019_bib0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/cncr.21723","article-title":"Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2011.12.019_bib0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1200\/JCO.2010.30.2554","article-title":"Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications","volume":"29","author":"Marcucci","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.12.019_bib0025","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.1989.7.9.1268","article-title":"On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group","volume":"7","author":"Lowenberg","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.12.019_bib0030","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.12.019_bib0035","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cncr.22496","article-title":"A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment","volume":"109","author":"Burnett","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2011.12.019_bib0040","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archinte.162.14.1597","article-title":"The outcomes and costs of acute myeloid leukemia among the elderly","volume":"162","author":"Menzin","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.leukres.2011.12.019_bib0045","series-title":"Clinical practice guidelines in oncology \u2013 acute myeloid Leukemia. Version 2.2011","author":"National Comprehensive Cancer Network","year":"2011"},{"key":"10.1016\/j.leukres.2011.12.019_bib0050","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/cncr.23855","article-title":"Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia","volume":"113","author":"Roboz","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2011.12.019_bib0055","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1182\/blood-2008-08-172726","article-title":"Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide","volume":"113","author":"Karp","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.12.019_bib0060","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2006-04-014357","article-title":"A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia","volume":"109","author":"Lancet","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.12.019_bib0065","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1080\/10428190903050013","article-title":"Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial","volume":"50","author":"Raza","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2011.12.019_bib0070","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1182\/blood-2008-09-177030","article-title":"A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response","volume":"113","author":"Pratz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.12.019_bib0075","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.12.019_bib0080","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/cncr.22976","article-title":"Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia","volume":"110","author":"Baz","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2011.12.019_bib0085","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1200\/JCO.2009.23.8329","article-title":"Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia","volume":"28","author":"Fenaux","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.12.019_bib0090","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1073\/pnas.1002650107","article-title":"Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine","volume":"107","author":"Blum","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.12.019_bib0095","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.6504","article-title":"Results from a randomized phase III trial of decitabine versus supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed AML","author":"Thomas","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.12.019_bib0100","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1200\/JCO.2009.25.4821","article-title":"Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome","volume":"28","author":"McClune","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611006102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611006102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T11:56:12Z","timestamp":1543233372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611006102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0145212611006102"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.12.019","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}